Guangzhou Boji Financials
| 300404 Stock | 9.52 0.01 0.10% |
Guangzhou | Select Account or Indicator |
Understanding current and past Guangzhou Boji Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Guangzhou Boji's financial statements are interrelated, with each one affecting the others. For example, an increase in Guangzhou Boji's assets may result in an increase in income on the income statement.
Please note, the presentation of Guangzhou Boji's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Guangzhou Boji's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Guangzhou Boji's management manipulating its earnings.
Guangzhou Boji Stock Summary
Guangzhou Boji competes with Cultural Investment, Youngy Health, Zhejiang Construction, Shandong Sinoglory, and Xiandai Investment. Guangzhou Boji is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100001Y00 |
| Business Address | Building A, Vanke |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bojicro.com |
| Phone | 86 40 0002 0628 |
You should never invest in Guangzhou Boji without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Guangzhou Stock, because this is throwing your money away. Analyzing the key information contained in Guangzhou Boji's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Guangzhou Boji Key Financial Ratios
Guangzhou Boji's financial ratios allow both analysts and investors to convert raw data from Guangzhou Boji's financial statements into concise, actionable information that can be used to evaluate the performance of Guangzhou Boji over time and compare it to other companies across industries.| Revenue | 555.83 M | ||||
| Gross Profit | 232.17 M | ||||
| EBITDA | 36.86 M | ||||
| Net Income | 24.34 M | ||||
| Total Asset | 1.43 B |
Guangzhou Boji Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 749.6M | 1.1B | 1.3B | 1.4B | 1.6B | 1.7B | |
| Other Current Liab | 153.9M | 175.9M | 6.3M | 6.7M | 7.7M | 7.3M | |
| Other Liab | 17.2M | 16.1M | 18.7M | 16.3M | 18.8M | 11.4M | |
| Retained Earnings | 131.8M | 170.6M | 167.5M | 186.5M | 214.5M | 142.9M | |
| Accounts Payable | 50.9M | 55.8M | 79.0M | 101.4M | 116.7M | 122.5M | |
| Cash | 146.4M | 384.5M | 306.9M | 397.2M | 456.7M | 479.6M | |
| Other Assets | 39.7M | 45.0M | 84.2M | 80.4M | 92.4M | 97.0M | |
| Net Receivables | 42.6M | 71.7M | 91.5M | 114.4M | 131.6M | 74.5M | |
| Inventory | 93.2M | 148.3M | 168.4M | 199.1M | 228.9M | 240.4M | |
| Other Current Assets | 46.4M | 39.0M | 3.8M | 1.9M | 2.2M | 2.1M | |
| Total Liab | 264.6M | 291.8M | 376.7M | 448.8M | 516.1M | 542.0M | |
| Intangible Assets | 23.4M | 22.5M | 22.4M | 21.9M | 25.2M | 22.8M | |
| Common Stock | 133.9M | 173.3M | 226.6M | 261.5M | 300.7M | 315.7M | |
| Net Tangible Assets | 360.5M | 370.5M | 392.7M | 763.4M | 877.9M | 483.8M | |
| Total Current Assets | 374.9M | 700.1M | 701.2M | 815.2M | 937.5M | 514.5M | |
| Short Long Term Debt | 32.0M | 25.2M | 20.2M | 29.9M | 34.4M | 19.4M | |
| Net Invested Capital | 476.2M | 839.2M | 929.5M | 1.1B | 1.2B | 719.5M | |
| Net Working Capital | 128.9M | 429.3M | 401.0M | 457.7M | 526.3M | 287.3M | |
| Capital Stock | 226.6M | 261.5M | 368.4M | 382.0M | 439.3M | 283.4M |
Guangzhou Boji Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 1.5M | 1.4M | 704.3K | 1.5M | 1.8M | 1.9M | |
| Total Revenue | 260.5M | 324.2M | 423.7M | 555.8M | 639.2M | 671.2M | |
| Operating Income | 37.8M | 54.5M | 34.8M | 33.0M | 38.0M | 30.7M | |
| Cost Of Revenue | 146.7M | 184.1M | 263.0M | 370.5M | 426.1M | 447.4M | |
| Income Before Tax | 27.8M | 47.1M | 24.6M | 17.6M | 15.9M | 17.8M | |
| Net Income | 17.0M | 38.9M | 27.7M | 24.3M | 21.9M | 15.4M | |
| Income Tax Expense | 4.1M | 297.5K | 2.9M | 3.6M | 3.2M | 2.1M | |
| Research Development | 26.4M | 27.6M | 43.7M | 55.0M | 63.2M | 66.4M | |
| Gross Profit | 113.8M | 140.1M | 160.7M | 185.3M | 213.1M | 110.9M | |
| Ebit | 8.2M | 5.7M | 17.1M | 54.5M | 62.7M | 65.9M | |
| Minority Interest | 40.8M | (4.6M) | (1.6M) | (2.9M) | (2.6M) | (2.4M) | |
| Tax Provision | 2.9M | 3.6M | (4.7M) | (9.6M) | (8.6M) | (8.2M) | |
| Net Interest Income | (1.3M) | 327.1K | 870.9K | 436.2K | 392.6K | 412.2K | |
| Interest Income | 359.8K | 1.9M | 1.7M | 2.1M | 2.5M | 2.6M | |
| Ebitda | 27.3M | 44.2M | 66.4M | 46.8M | 53.8M | 33.8M |
Guangzhou Boji Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Guangzhou Boji Medical. It measures of how well Guangzhou is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Guangzhou Boji brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Guangzhou had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Guangzhou Boji has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Capital Expenditures | 31.4M | 54.0M | 117.7M | 62.2M | 71.5M | 48.3M | |
| Net Income | 17.0M | 38.9M | 27.7M | 24.3M | 21.9M | 15.4M | |
| Dividends Paid | 3.2M | 1.2M | 6.8M | 8.0M | 7.2M | 5.2M | |
| Change To Inventory | (1.3M) | (56.5M) | (23.5M) | (33.5M) | (30.2M) | (31.7M) | |
| Investments | 1.7M | (34.3M) | (162.0M) | (33.1M) | (29.8M) | (31.3M) | |
| Change In Cash | 89.0M | 238.1M | (79.6M) | 90.2M | 103.8M | 109.0M | |
| Net Borrowings | (3.3M) | 7.3M | 16.7M | (6.9M) | (7.9M) | (7.5M) | |
| Depreciation | 14.5M | 17.9M | 21.5M | 23.3M | 26.7M | 14.3M | |
| Change To Netincome | 10.5M | 14.8M | 18.5M | 9.4M | 10.9M | 14.2M | |
| End Period Cash Flow | 146.4M | 384.5M | 304.9M | 395.2M | 454.4M | 477.2M | |
| Free Cash Flow | 65.6M | (23.9M) | (89.6M) | (26.2M) | (23.6M) | (24.8M) | |
| Other Non Cash Items | 3.0M | 2.9M | 3.5M | 5.8M | 6.6M | 7.0M |
Guangzhou Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guangzhou Boji's current stock value. Our valuation model uses many indicators to compare Guangzhou Boji value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guangzhou Boji competition to find correlations between indicators driving Guangzhou Boji's intrinsic value. More Info.Guangzhou Boji Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Guangzhou Boji Medical is roughly 7.04 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Guangzhou Boji by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Guangzhou Boji's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Guangzhou Boji Medical Systematic Risk
Guangzhou Boji's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Guangzhou Boji volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Guangzhou Boji Medical correlated with the market. If Beta is less than 0 Guangzhou Boji generally moves in the opposite direction as compared to the market. If Guangzhou Boji Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Guangzhou Boji Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Guangzhou Boji is generally in the same direction as the market. If Beta > 1 Guangzhou Boji moves generally in the same direction as, but more than the movement of the benchmark.
Guangzhou Boji Medical Total Assets Over Time
Guangzhou Boji Thematic Clasifications
Guangzhou Boji Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Guangzhou Boji March 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Guangzhou Boji help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Guangzhou Boji Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Guangzhou Boji Medical based on widely used predictive technical indicators. In general, we focus on analyzing Guangzhou Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Guangzhou Boji's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 19.16 | |||
| Value At Risk | (4.90) | |||
| Potential Upside | 4.64 |
Complementary Tools for Guangzhou Stock analysis
When running Guangzhou Boji's price analysis, check to measure Guangzhou Boji's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Boji is operating at the current time. Most of Guangzhou Boji's value examination focuses on studying past and present price action to predict the probability of Guangzhou Boji's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Boji's price. Additionally, you may evaluate how the addition of Guangzhou Boji to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |